Topsfield, MA, United States of America

Yi Fang

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Innovative Contributions of Yi Fang in Biochemical Sequencing**

Introduction

Yi Fang is an accomplished inventor based in Topsfield, MA, known for his significant contributions in the field of biochemical sequencing. With one patent to his name, he has demonstrated exceptional expertise in utilizing immobilized enzymes for innovative applications.

Latest Patents

The patent held by Yi Fang is titled "Application of immobilized enzymes for nanopore library construction." This invention outlines methods for preparing a library essential for sequencing operations. Specifically, it describes a coupled reaction wherein a population of nucleic acid fragments is contacted with a tailing enzyme to produce tailed fragments. The process continues by ligating a sequencing adapter to these tailed fragments, resulting in adapter-tagged fragments. Additionally, the patent addresses the separation of these adapter-tagged fragments from the enzymes involved, enhancing the efficiency of library preparation. The approach also highlights the potential use of immobilized enzymes, which can offer significant advantages in sequencing applications.

Career Highlights

Yi Fang is currently associated with New England Biolabs, Inc., where he leverages his skills and knowledge in biological applications. His innovative work reflects a deep understanding of enzymatic processes and their role in advancing genetic sequencing technologies.

Collaborations

In his career, Yi Fang has collaborated with notable colleagues such as Ming-Qun Xu and Aihua Zhang. These partnerships have allowed for a synergistic approach to research, enhancing the development and application of groundbreaking methodologies in the field.

Conclusion

The inventive prowess of Yi Fang represents a significant advancement in the realm of biochemical sequencing through his patent on immobilized enzyme applications. As part of the team at New England Biolabs, Inc., he continues to contribute to the innovation landscape, paving the way for future developments in genetic research and sequencing technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…